| Ticker Details |
|
Repare Therapeutics Inc.
|
| IPO Date: |
May 2, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$114.24M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 3.06%
|
| Avg Daily Range (30 D): |
$0.02 | 0.74%
|
| Avg Daily Range (90 D): |
$0.03 | 1.68%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.24M |
| Avg Daily Volume (30 D): |
.36M |
| Avg Daily Volume (90 D): |
.73M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
533 |
| Avg Trade Size (Sh.) (90 D): |
332 |
| Institutional Trades |
| Total Institutional Trades: |
60 |
| Avg Institutional Trade: |
$1.66M |
| Avg Institutional Trade (30 D): |
$4.15M |
| Avg Institutional Trade (90 D): |
$2.2M |
| Avg Institutional Trade Volume: |
.26M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.49M |
| Avg Closing Trade (30 D): |
$2.61M |
| Avg Closing Trade (90 D): |
$2.61M |
| Avg Closing Volume: |
162.82K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.08
|
$-.39
|
|
Diluted EPS
|
|
$.08
|
$-.39
|
|
Revenue
|
|
$15.01M
|
$5.92M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
|
$3.26M
|
$-16.74M
|
|
Operating Income / Loss
|
|
$1.13M
|
$-17.78M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
|
$5.17M
|
$-16.8M
|
|
PE Ratio
|
|
|
|
|
|
|